United States · Series D startup
4 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$32Mraised across 4 rounds since 2007, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by htgenomics.comSEC filing: $10M sold, first sale Feb 2011
No investor was named in the report.
From a historical funding recordSEC filing: $1.7M sold, first sale Jul 2010
No investor was named in the report.
From a historical funding recordSEC filing: $4.3M sold, first sale Nov 2008
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Valley VenturesMerckNovo Holdings A/SArcturus Capital
Fletcher Spaght, Inc.Solstice CapitalSol Cap IncMissing a round, or an investor who was in one? Tell us.
High Throughput Genomics's investors include Valley Ventures, Merck, Novo Holdings A/S, Arcturus Capital and Fletcher Spaght, Inc., and 2 more on record.
High Throughput Genomics has raised $32M across 4 rounds since 2007.
High Throughput Genomics's most recent round was a Series D of $16M in Feb 2011.
Its most recent round, $16M in Feb 2011, is also its largest on record.
High Throughput Genomics's first round on record, in Oct 2007, was backed by Arcturus Capital, Valley Ventures and Solstice Capital and 1 others.
High Throughput Genomics's latest named round is a Series D, in Feb 2011.
High Throughput Genomics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·